ATLL Cell Therapy
Adult T-cell Leukemia/Lymphoma (ATLL)
PreclinicalDevelopment initiated
Key Facts
Indication
Adult T-cell Leukemia/Lymphoma (ATLL)
Phase
Preclinical
Status
Development initiated
Company
About ARC Therapies
National Cancer Center Japan spin-out developing novel cell and gene therapies for oncology, with programs targeting ATLL and microbiome-based immunotherapies.
View full company profile